Novo Nordisk at a Tipping Point: Oral Wegovy Nears EU Market as US Formulary Edge Disappears
EMA recommends oral Wegovy approval as CVS Caremark removes Novo Nordisk’s exclusivity, adding Lilly’s drugs; stock plunges 44%…
Browsing Tag